476 related articles for article (PubMed ID: 32593277)
21. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
22. Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients.
Lei K; Li J; Tu Z; Liu F; Ye M; Wu M; Zhu Y; Luo M; Lin L; Tao C; Huang K; Zhu X
Front Oncol; 2021; 11():665870. PubMed ID: 34123829
[TBL] [Abstract][Full Text] [Related]
23. A novel immune-related gene-based prognostic signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Lv D; Wu X; Chen X; Yang S; Chen W; Wang M; Liu Y; Gu D; Zeng G
Cancer Immunol Immunother; 2021 Dec; 70(12):3587-3602. PubMed ID: 33934205
[TBL] [Abstract][Full Text] [Related]
24. Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs.
Chen S; Sun Y; Zhu X; Mo Z
Int J Gen Med; 2021; 14():8149-8160. PubMed ID: 34803397
[TBL] [Abstract][Full Text] [Related]
25. Discovery and Verification of an Immune-Related Gene Pairs Signature for Predicting Prognosis in Head and Neck Squamous Cell Carcinoma.
He J; Fang X; Han M
Front Genet; 2021; 12():654657. PubMed ID: 34108990
[TBL] [Abstract][Full Text] [Related]
26. Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma.
Zhang X; Ping S; Wang A; Li C; Zhang R; Song Z; Gao C; Wang F
Int J Gen Med; 2021; 14():8611-8620. PubMed ID: 34849006
[TBL] [Abstract][Full Text] [Related]
27. Development and validation of an immune-related gene pairs signature in colorectal cancer.
Wu J; Zhao Y; Zhang J; Wu Q; Wang W
Oncoimmunology; 2019; 8(7):1596715. PubMed ID: 31143520
[TBL] [Abstract][Full Text] [Related]
28. Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma.
Feng X; Mu S; Ma Y; Wang W
Front Mol Biosci; 2021; 8():715728. PubMed ID: 34660693
[TBL] [Abstract][Full Text] [Related]
29. Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer.
Cao K; Ma T; Ling X; Liu M; Jiang X; Ma K; Zhu J; Ma J
Ann Transl Med; 2021 Oct; 9(20):1591. PubMed ID: 34790797
[TBL] [Abstract][Full Text] [Related]
30. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
[TBL] [Abstract][Full Text] [Related]
32. 29 immune-related genes pairs signature predict the prognosis of cervical cancer patients.
Nie H; Bu F; Xu J; Li T; Huang J
Sci Rep; 2020 Aug; 10(1):14152. PubMed ID: 32843657
[TBL] [Abstract][Full Text] [Related]
33. Identification and validation of an immune prognostic signature in colorectal cancer.
Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer.
Xiong H; Gao H; Hu J; Dai Y; Wang H; Fu M; Qi T; Li L; Xia Q; Jin X; Cui Z; Kang W
J Oncol; 2021; 2021():5345181. PubMed ID: 34354750
[TBL] [Abstract][Full Text] [Related]
35. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
[TBL] [Abstract][Full Text] [Related]
36. A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy.
Li X; Huang H; Zhang J; Jiang F; Guo Y; Shi Y; Guo Z; Ao L
Prostate; 2020 Apr; 80(5):376-387. PubMed ID: 31961962
[TBL] [Abstract][Full Text] [Related]
37. Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer.
Mazzu YZ; Armenia J; Nandakumar S; Chakraborty G; Yoshikawa Y; Jehane LE; Lee GM; Atiq M; Khan N; Schultz N; Kantoff PW
Mol Oncol; 2020 Aug; 14(8):1881-1897. PubMed ID: 32385899
[TBL] [Abstract][Full Text] [Related]
38. Identification of a five gene signature to predict time to biochemical recurrence after radical prostatectomy.
Corradi JP; Cumarasamy CW; Staff I; Tortora J; Salner A; McLaughlin T; Wagner J
Prostate; 2021 Jul; 81(10):694-702. PubMed ID: 34002865
[TBL] [Abstract][Full Text] [Related]
39. A united risk model of 11 immune‑related gene pairs and clinical stage for prediction of overall survival in clear cell renal cell carcinoma patients.
Tao Z; Zhang E; Li L; Zheng J; Zhao Y; Chen X
Bioengineered; 2021 Dec; 12(1):4259-4277. PubMed ID: 34304692
[TBL] [Abstract][Full Text] [Related]
40. Development and verification of an immune-related gene pairs prognostic signature in ovarian cancer.
Zhang B; Nie X; Miao X; Wang S; Li J; Wang S
J Cell Mol Med; 2021 Mar; 25(6):2918-2930. PubMed ID: 33543590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]